Australia’s definition of death preventing use of latest organ transplant technology
The Australian government will launch an Australian Law Reform Commission inquiry to update human tissue legislation that hasn't been overhauled since 1977. The review aims to align the legal definition of death with modern practices such as normothermic regional perfusion, harmonise state rules an…
On Thursday the Australian government announced a new Australian Law Reform Commission (ALRC) inquiry that will examine the nation’s human tissue laws – the first comprehensive review in almost five decades. The inquiry is intended to modernise the legal definition of death, harmonise state and territory regulations, and consider consent frameworks, all with the goal of unlocking advanced organ‑retrieval technologies that are currently blocked by outdated legislation.
Why the definition of death matters for transplants
Australia currently recognises two legal pathways for organ donation: the irreversible cessation of circulatory function or the irreversible cessation of all brain activity. While both definitions are medically valid, the circulatory‑death definition creates a legal barrier to using normothermic regional perfusion (NRP), a technique that restores temporary blood flow to organs after cardiac arrest to prevent damage.
Prof. Angela Webster, a transplant physician at Westmead Hospital and board member of the Transplantation Society of Australia and New Zealand, explained that NRP can keep organs viable by supplying oxygenated blood while the donor is legally declared dead. However, because the law requires an absolute stoppage of blood circulation, any re‑establishment of flow – even briefly – conflicts with the current definition and makes the procedure unlawful.
Webster argues that the definition should be revised to focus on the cessation of circulation to the brain, mirroring the approach used in most other high‑income countries where NRP is already routine. She notes that evidence shows clear benefits for liver transplants and that ongoing research may extend those gains to kidneys, lungs and hearts.
State‑level inconsistencies add another layer of complexity
Beyond the definition of death, each Australian state and territory operates under its own Human Tissue Act, leading to a patchwork of rules that affect how doctors can manage organ procurement. For example, in New South Wales clinicians may administer heparin – an anticoagulant that reduces clotting – before death is declared, whereas several other jurisdictions forbid any medication after death determination.
These discrepancies can influence the quality of retrieved organs and create inequitable outcomes for patients depending on where the donation occurs. Aligning the legislation would provide a uniform framework, ensuring that every Australian donor receives the same standard of care and that transplant teams can apply best‑practice techniques nationwide.
The upcoming ALRC inquiry: scope and expectations
All Commonwealth, state and territory health ministers have pledged joint funding for the inquiry, and they are drafting terms of reference that will be released later in 2024 when Attorney‑General Mark Dreyfus formally refers the matter to the ALRC. The inquiry will review:
- The legal definition of death and its compatibility with modern medical technologies such as NRP.
- Variations in consent and authorisation processes across jurisdictions, including the potential impact of an opt‑out system.
- Procedural differences that affect organ preservation, such as the use of anticoagulants before death is declared.
- Family experience and communication standards to ensure consistent, compassionate handling of donor families.
Federal Assistant Minister for Health Ged Kearney highlighted that the last full review of tissue laws occurred in 1977, underscoring the urgency of reform. While an opt‑out model is on the table, DonateLife medical director Dr. Helen Opdam cautioned that family consent remains the decisive factor, regardless of the legislative model.
Potential impact on donation rates and patient outcomes
Australia’s current consent rate sits at roughly 56 %, but spikes above 80 % when families are aware of the donor’s wishes. By simplifying legal pathways and providing clear, uniform guidance to clinicians, the inquiry could improve both the quantity and quality of donated organs.
For patients awaiting transplants, the ability to use NRP could mean shorter waiting times and better graft survival, especially for liver recipients where the technology has already demonstrated superiority. Moreover, a harmonised legal environment would position Australia to contribute to international research on NRP for other organs, reinforcing its reputation as a leader in transplantation innovation.
Human stories behind the policy debate
Nick Brown, whose wife Leanne died by suicide in 2019, shared how her organ donation helped him cope with grief. Leanne’s organs saved four lives, and Brown hopes that future families will receive the same sense of purpose and pride that he found in her final act. Stories like his underscore why legal clarity matters not just for clinicians but for the families who navigate the donation process.
As the inquiry moves forward, stakeholders—including transplant surgeons, ethicists, patient advocacy groups and families—will have the opportunity to shape a framework that balances scientific progress with ethical safeguards. The outcome could set a new benchmark for how nations align law with medical innovation.
Why it matters
Updating Australia’s death definition and harmonising tissue laws could unlock life‑saving transplant technologies and create a fairer, more efficient donation system.
Key points
- The ALRC will review human tissue legislation for the first time since 1977.
- Current legal definition of circulatory death blocks use of normothermic regional perfusion.
- State and territory rules differ on medication and consent, creating inequities.
- Reform could improve organ quality, increase donation rates and align Australia with international standards.
Frequently asked questions
What is normothermic regional perfusion (NRP) and why is it important?
NRP is a technique that temporarily restores oxygenated blood flow to organs after cardiac death, reducing damage and improving transplant outcomes, especially for livers.
How does the current definition of death limit organ donation in Australia?
The law requires an absolute stop to blood circulation; any re‑established flow, even briefly for NRP, is seen as contradictory, preventing the use of the technology.
Will Australia move to an opt‑out organ donation system?
The inquiry will consider consent frameworks, but experts say an opt‑out model alone is unlikely to raise donation rates without family agreement.
Which government bodies are funding the ALRC inquiry?
The Commonwealth, all state and territory health ministers have agreed to jointly fund the review.
